Integrated PET/CT system for staging and surveillance of skull base tumors

Head Neck. 2007 Jun;29(6):537-45. doi: 10.1002/hed.20545.

Abstract

Background: The utility of preoperative and postoperative whole body integrated positron emission tomography-computed tomography (PET-CT) scanning for staging and follow-up in patients with skull base tumors is undetermined.

Methods: We prospectively evaluated PET-CT findings in 47 patients using 57 scans. Most (35/47, 75%) had anterior skull base tumors and the majority (74%) had advanced-stage (III-IV) disease.

Results: The scans showed high sensitivity for detection of various types of malignant tumors and provided 39 items of additional information, changing the clinical staging and management of 11 patients (23%). Recurrence of primary tumors was detected in 8 patients, positive regional (neck) metastases in 3, and distant metastases in 3. The positive uptake was due to osteoradionecrosis in 2 other patients. The sensitivity of PET-CT was 0.77 and the specificity was 0.81 (0.83 positive predictive value and 0.76 negative predictive value).

Conclusions: PET-CT provides accurate data on anatomy, tumor staging, and early disease recurrence in the skull base.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Postoperative Care
  • Predictive Value of Tests
  • Preoperative Care
  • Prospective Studies
  • Sarcoma / pathology
  • Sarcoma / therapy
  • Sensitivity and Specificity
  • Skull Base Neoplasms / pathology*
  • Skull Base Neoplasms / therapy
  • Tomography, X-Ray Computed*